Sp907
AGA MORTON I GROSSMAN AWARD PRESENTATION
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
Increasing scientific evidence supports the key role of brain-gut interactions in chronic gastrointestinal (GI) disorders such as irritable bowel syndrome (IBS). IBS and other functional GI disorders have been redefined as disorders of gut-brain interaction (DGBI) which is associated with alterations in visceral sensitivity, gut motility and secretion, immune function, gut microbiome and/or central nervous system processing of visceral events. Bidirectional communication between the brain and gut (including the microbiome) occurs via neural, immune, and hormonal pathways. The brain-gut axis can be significantly impacted both centrally (e.g., stressful life events, psychological symptoms) and peripherally (e.g., infection, food) leading to the onset or exacerbation of IBS. Understanding the clinical presentation and the pathophysiology of IBS allows us to apply our knowledge to enhancing effective patient care and developing novel diagnostic and therapeutic approaches. LIVE STREAM SESSION
Increasing scientific evidence supports the key role of brain-gut interactions in chronic gastrointestinal (GI) disorders such as irritable bowel syndrome (IBS). IBS and other functional GI disorders have been redefined as disorders of gut-brain interaction (DGBI) which is associated with alterations in visceral sensitivity, gut motility and secretion, immune function, gut microbiome and/or central nervous system processing of visceral events. Bidirectional communication between the brain and gut (including the microbiome) occurs via neural, immune, and hormonal pathways. The brain-gut axis can be significantly impacted both centrally (e.g., stressful life events, psychological symptoms) and peripherally (e.g., infection, food) leading to the onset or exacerbation of IBS. Understanding the clinical presentation and the pathophysiology of IBS allows us to apply our knowledge to enhancing effective patient care and developing novel diagnostic and therapeutic approaches. LIVE STREAM SESSION
Presenter
Drossman Gastroenterology
Tracks
Related Products
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
AGA Morton I. Grossman Distinguished Lectureship — Brain-Gut Interactions in IBS: Novel Applications for Clinical Practice
Increasing scientific evidence supports the key role of brain-gut interactions in chronic gastrointestinal (GI) disorders such as irritable bowel syndrome (IBS)…
CHRONIC ABDOMINAL PAIN
Back by popular demand, the experts will share and debate the evidence and their approaches to chronic pain, defecatory disorders, dyspepsia. and gastroparesis…
